Atomo Diagnostics Ltd (ASX: AT1) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Atomo Diagnostics Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $12.63 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 902.43 million
Earnings per share -0.004
Dividend per share N/A
Year To Date Return -61.11%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Atomo Diagnostics Ltd (ASX: AT1)
    Latest News

    Doctor doing a telemedicine using laptop at a medical clinic
    Share Gainers

    Guess which ASX healthcare stock just exploded 63% on Federal budget funding news!

    Investors are bidding up the ASX healthcare stock amid extra funding in the Federal budget.

    Read more »

    Two happy scientists analysing test results.
    Share Gainers

    Guess which ASX pharmaceutical stock just rocketed 122%!

    Investors are piling into the ASX pharmaceutical stock on Wednesday.

    Read more »

    Young doctor raising arms in air with hands in fists celebrating a new development.
    Healthcare Shares

    3 ASX healthcare shares rocketing 20% to 100% today

    These ASX shares are thumping the market on Tuesday and making their shareholders smile.

    Read more »

    laboratory workers looking disappointed
    Earnings Results

    3 ASX healthcare shares punished following full-year results

    It wasn't so rosy for all those reporting earnings today

    Read more »

    a woman winces as she inserts a home diagnostic test for COVID-19 up her nose with her sofa in the background.
    Earnings Results

    Negative result: Atomo Diagnostics (ASX: AT1) shares plunge 18% on half-year earnings

    What did the diagnostics report in its results?

    Read more »

    A man wearing a mask punches the air with joy after getting a negative COVID result on a rapid antigen test.
    Coronavirus News

    Why are ASX COVID test shares climbing today?

    COVID-19 tests are in focus again today.

    Read more »

    Health workers shake hands and congratulate each other on good news.
    Healthcare Shares

    Here's why the Atomo (ASX:AT1) share price is rocketing 17% today

    Atomo is cementing its presence across key markets.

    Read more »

    female nurse in scrubs
    Healthcare Shares

    Why has the Atomo Diagnostics (ASX: AT1) share price surged 50% since Christmas?

    Could this be why the company's stock has taken off lately?

    Read more »

    A doctor in a white coat sits at her computer with finger on mouth thinking about something in her office with medical equipment in the background.
    Healthcare Shares

    Why is the Atomo Diagnostics (ASX:AT1) share price wobbling on Thursday?

    It's been a busy week so far for the medical devices company

    Read more »

    Woman prepares to insert a swab in her nose to test for COVID-19 at home.
    Healthcare Shares

    Is AM Diagnostics listed on the ASX?

    The supplier of Australia's only approved at-home COVID-19 tests is the talk of the ASX today.

    Read more »

    share price dropping
    Share Fallers

    Why Afterpay, Atomo, Opthea, & Sealink shares are falling today

    These ASX shares are in the red on Tuesday...

    Read more »

    A young woman with tattoos puts both thumbs down and scrunches her face.
    ASX Share Market News

    Here's why the Atomo (ASX:AT1) share price is crashing 9% today

    This ASX share is having a bad start to the week...

    Read more »

    AT1 ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Atomo Diagnostics Ltd

    Atomo Diagnostics Ltd. engages in manufacturing, research, development, and design of in-vitro medical devices for blood-based rapid diagnostic testing (RDT) for professional use and self-testing. It offers its products through the AtomoRapid range of RDT platforms. The company was founded by John Kelly in 2010 and is headquartered in Leichhardt, Australia.

    AT1 Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    30 Oct 2026 $0.01 $0.00 0.00% 7,899,350 $0.02 $0.02 $0.01
    29 Oct 2026 $0.02 $0.00 0.00% 4,569,811 $0.02 $0.02 $0.02
    28 Oct 2026 $0.02 $0.00 0.00% 547,368 $0.02 $0.02 $0.02
    27 Oct 2026 $0.02 $0.00 0.00% 1,716,160 $0.02 $0.02 $0.02
    26 Oct 2026 $0.02 $0.00 0.00% 1,250 $0.02 $0.02 $0.02
    23 Oct 2026 $0.02 $0.00 0.00% 10,000 $0.02 $0.02 $0.02
    22 Oct 2026 $0.02 $0.00 0.00% 82,000 $0.02 $0.02 $0.02
    21 Oct 2026 $0.02 $0.00 0.00% 500,000 $0.02 $0.02 $0.02
    19 Oct 2026 $0.02 $0.00 0.00% 20,962 $0.02 $0.02 $0.02
    16 Oct 2026 $0.02 $0.00 0.00% 318,285 $0.02 $0.02 $0.02
    15 Oct 2026 $0.02 $0.00 0.00% 258,479 $0.02 $0.02 $0.02
    14 Oct 2026 $0.02 $0.00 0.00% 14,336 $0.02 $0.02 $0.02
    09 Oct 2026 $0.02 $0.00 0.00% 421,141 $0.02 $0.02 $0.02
    08 Oct 2026 $0.02 $0.00 0.00% 1,556,120 $0.02 $0.02 $0.02
    07 Oct 2026 $0.02 $0.00 0.00% 59,143 $0.02 $0.02 $0.02
    06 Oct 2026 $0.02 $0.00 0.00% 1,930,795 $0.02 $0.02 $0.02

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    12 Dec 2025 Cheri Walker Issued 1,000,000 $40,000
    Issue of options.
    12 Dec 2025 Anthony May Issued 700,000 $28,000
    Issue of options.
    12 Dec 2025 Patrick Cook Issued 1,400,000 $56,000
    Issue of options.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Cheri Louise Walker Executive DirectorInterim CEO Aug 2026
    Dr Walker is an executive with more than twenty-five years of experience working with life science and diagnostic companies. She is currently the Chief Executive Officer of Zeta Corporation. She has previously held senior executive positions at Abcam, Charles River Labs, Qiagen, and Life Technologies, now part of ThermoFisher. She is a member of the Risk Committee.
    Mr Anthony May Non-Executive Director May 2025
    Mr May has held various Director roles across international corporations including Hoechst Germany, Microgenics Corporation USA, Fisher Scientific and Thermo Fisher Scientific. With experience across public and private pathology laboratories, as well as sales and management roles in the IVD supply sector. He is the chairperson of the Risk Committee.
    Mr Patrick Cook Non-Executive Director May 2025
    Mr Cook has over 35 years of experience as a senior executive in medical devices & point-of-care diagnostics sectors within various multinational, private and listed biotechnology companies. He is member of Risk Committee.
    Mr Mathew Leslie Watkins Company Secretary Jun 2024
    -
    Mathew Leslie Watkins Company Secretary
    -
    Chandra Sukumar COO
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    GZ Family Holdings Pty Ltd 89,895,644 9.96%
    Dalraida Holdings Pty Limited 65,120,000 7.22%
    Global Health Investment Fund 48,230,000 5.34%
    Wellgrow Investments Pty Ltd 28,648,649 3.17%
    GZ Super Investments Pty Ltd 27,027,027 2.99%
    Australia West Holdings Pty 21,050,000 2.33%
    Mr Xiaoyi Lin 20,000,000 2.22%
    BNP Paribas Nominees Pty Ltd 19,455,118 2.16%
    Australia North Holdings Pty 16,000,000 1.77%
    Citicorp Nominees Pty Limited 15,985,025 1.77%
    Grand Challenges Canada 11,390,824 1.26%
    Liverbird Pty Ltd 10,931,653 1.21%
    I D E Pty Ltd 9,032,248 1.00%
    John Michael Kelly 8,991,870 1.00%
    Rue Des Rocs Pty Ltd 8,000,000 0.89%
    Mark Andrew Smith 7,790,224 0.86%
    Mr Ian Fredrick Johnson 7,506,080 0.83%
    Mr Leo James Lynch and Ms Judith Anne Beswick 7,321,121 0.81%
    Ms Zeyu Shi 6,934,108 0.77%
    Mr Yichao Yu 6,558,559 0.73%

    Profile

    since

    Note